{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T20:02:13Z","timestamp":1762113733847},"reference-count":6,"publisher":"Jaypee Brothers Medical Publishing","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.4103\/ijccm.ijccm_497_17","type":"journal-article","created":{"date-parts":[[2018,4,18]],"date-time":"2018-04-18T07:01:46Z","timestamp":1524034906000},"page":"311-313","source":"Crossref","is-referenced-by-count":3,"title":["Indolent systemic mastocytosis manifesting as protracted anaphylactic shock"],"prefix":"10.5005","volume":"22","author":[{"given":"Saikat","family":"Sengupta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sujoy","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chandrashish","family":"Chakravarty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manidipam","family":"Chatterjee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shilpa","family":"Bhartia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vikash","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2914","published-online":{"date-parts":[[2018]]},"reference":[{"key":"ref=1","doi-asserted-by":"crossref","unstructured":"1. Hartmann K, Henz BM. Mastocytosis: Recent advances in defining the disease. Br J Dermatol 2001;144:682-95.","DOI":"10.1046\/j.1365-2133.2001.04123.x"},{"key":"ref=2","doi-asserted-by":"crossref","unstructured":"2. Valent P, Sperr WR, Akin C. How I treat patients with advanced systemic mastocytosis. Blood 2010;116:5812-7.","DOI":"10.1182\/blood-2010-08-292144"},{"key":"ref=3","unstructured":"3. Nettleship E, Tay W. Rare forms of urticaria. Br Med J 1869;2:323-30."},{"key":"ref=4","doi-asserted-by":"crossref","unstructured":"4. Vardiman JW, Thiele J, Arber DA, Brunning RD, Borowitz MJ, Porwit A, et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: Rationale and important changes. Blood 2009;114:937-51.","DOI":"10.1182\/blood-2009-03-209262"},{"key":"ref=5","doi-asserted-by":"crossref","unstructured":"5. Valent P, Akin C, Sperr WR, Mayerhofer M, F\u00f6dinger M, Fritsche-Polanz R, et al. Mastocytosis: Pathology, genetics, and current options for therapy. Leuk Lymphoma 2005;46:35-48.","DOI":"10.1080\/10428190400010775"},{"key":"ref=6","doi-asserted-by":"crossref","unstructured":"6. Pardanani A. Systemic mastocytosis in adults: 2011 update on diagnosis, risk stratification, and management. Am J Hematol 2011;86:362-71.","DOI":"10.1002\/ajh.21982"}],"container-title":["Indian Journal of Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ijccm.org\/doi\/pdf\/10.4103\/ijccm.IJCCM_497_17","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,27]],"date-time":"2021-05-27T12:49:28Z","timestamp":1622119768000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ijccm.org\/doi\/10.4103\/ijccm.IJCCM_497_17"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":6,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2018]]}},"alternative-id":["10.4103\/ijccm.IJCCM_497_17"],"URL":"https:\/\/doi.org\/10.4103\/ijccm.ijccm_497_17","relation":{},"ISSN":["0972-5229","1998-359X"],"issn-type":[{"value":"0972-5229","type":"print"},{"value":"1998-359X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018]]}}}